Cite
Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects
MLA
J. Hirose, et al. “Improvement of Insulin Sensitivity and Dyslipidemia with a New Alpha-Glucosidase Inhibitor, Voglibose, in Nondiabetic Hyperinsulinemic Subjects.” Metabolism: Clinical and Experimental, vol. 45, no. 6, June 1996. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....473eaaa6c62eb0a7ad8a28694f1180d8&authtype=sso&custid=ns315887.
APA
J. Hirose, Motoyoshi Ikebuchi, Yutaka Harano, M. Suzuki, K Shinozaki, & Y Hara. (1996). Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects. Metabolism: Clinical and Experimental, 45(6).
Chicago
J. Hirose, Motoyoshi Ikebuchi, Yutaka Harano, M. Suzuki, K Shinozaki, and Y Hara. 1996. “Improvement of Insulin Sensitivity and Dyslipidemia with a New Alpha-Glucosidase Inhibitor, Voglibose, in Nondiabetic Hyperinsulinemic Subjects.” Metabolism: Clinical and Experimental 45 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....473eaaa6c62eb0a7ad8a28694f1180d8&authtype=sso&custid=ns315887.